Neoadjuvant therapy Clinical Trials
Conditions / Neoadjuvant therapy
Delta Trials catalogs 128 clinical trials for Neoadjuvant therapy in its publicly accessible dataset. Within this set, 44 currently recruiting participants and 18 trials have reached completion. This research occurs across 113 participating sites around the world. An additional 66 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 2 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
128
Total Trials
44
Recruiting
18
Completed
66
Other Active
2
Terminated since 2020
113
Study Locations
Browse by location (113 total)
- Shanghai, China 19 trialsAll trials in Shanghai, China
- Beijing, China 17 trialsAll trials in Beijing, China
- Guangzhou, China 14 trialsAll trials in Guangzhou, China
- Hangzhou, China 11 trialsAll trials in Hangzhou, China
- Nanjing, China 8 trialsAll trials in Nanjing, China
- Wuhan, China 7 trialsAll trials in Wuhan, China
- Fuzhou, China 7 trialsAll trials in Fuzhou, China
- Chengdu, China 4 trialsAll trials in Chengdu, China
- Jinan, China 4 trialsAll trials in Jinan, China
- Jinan, China 4 trialsAll trials in Jinan, China
- Tianjin, China 4 trialsAll trials in Tianjin, China
- Nanning, China 4 trialsAll trials in Nanning, China
- Xi’an, China 3 trialsAll trials in Xi’an, China
- Zhengzhou, China 3 trialsAll trials in Zhengzhou, China
- Chongqing, China 3 trialsAll trials in Chongqing, China
- Harbin, China 2 trialsAll trials in Harbin, China
- Västeras-, Sweden 2 trialsAll trials in Västeras-, Sweden
- Vasterås, Sweden 2 trialsAll trials in Vasterås, Sweden
- Montréal, Canada 2 trialsAll trials in Montréal, Canada
- Shijiazhuang, China 2 trialsAll trials in Shijiazhuang, China